Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: Report of a prospective study

American Journal of Gastroenterology

Volumn 100, Issue 10, 2005, Pages 2194-2200

  Park, Joong Won ^a,b   Park, Kyung Woo ^a   Cho, Sang Hyung ^a   Park, Hong Suk ^a   Lee, Woo Jin ^a   Lee, Do Hoon ^b   Kim, Chang Min ^a  

^a National Cancer Center   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IODINATED POPPYSEED OIL; VIRUS DNA; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE EXACERBATION; DNA DETERMINATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RISK ASSESSMENT; TUMOR GROWTH; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FOLLOW UP; LIVER TUMOR; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; VIROLOGY; VIRUS ACTIVATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VIRUS ACTIVATION;

EID: 27744605404     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00232.x     Document Type: Article

References (31)

1. Lemon SM Layden TJ Seeff L, et al. The 20th United States-Japan Joint Hepatitis Panel Meeting. Hepatology 2000 31 : 800 6.
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis 2004 11 : 97 107.
3. Lok AS Liang RH Chiu EK, et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991 100 : 182 8.
4. Yeo W Chan PK Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors. J Med Virol 2000 62 ( 3 299 307.
5. Hoofnagle JH Dusheiko GM Schafer DF, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982 96 : 447 9.
6. Markovic S Drozina G Vovk M, et al. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy - a prospective study in 305 patients. Hepatogastroenterology 1999 46 : 2925 30.
7. Cheng AL Hsiung CA Su IJ, et al. Steroid-free chemotherapy decreased risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 2003 37 ( 6 1320 8.
8. Chan TM Fang GXF Tang CSO, et al. Preemptive lamivudine therapy based on HBV DNA level in HbsAg-positive kidney allograft recipients. Hepatology 2002 36 : 1246 52.
9. Xunrong L Yan AW Liang R, et al. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy - Pathogenesis and management. Rev Med Virol 2001 11 : 287 99.
10. Yeo W Chan PK Ho WM, et al. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. J Clin Oncol 2004 22 : 927 34.
11. Idilman R Arat M Soydan E, et al. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepatol 2004 11 : 141 7.
12. Rossi G Pelizzari A Motta M, et al. Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. Br J Haematol 2001 115 : 58 62.
13. Lau GKK He ML Fong DYT, et al. Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation. Hepatology 2002 36 : 702 9.
14. Lau GKK Yiu HHY Fong DYT, et al. Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology 2003 125 : 1742 9.
15. Llovet JM Real MJ Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Lancet 2002 359 : 1734 9.
16. Yuen MF Chan AO Wong BC, et al. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: Results of a comparative study in 96 Chinese patients. Am J Gastroenterol. 2003 98 ( 5 1181 5.
17. Vizzini GB Luca A Marino IR. Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma [Research Letter]. Ann Intern Med 2003 138 : 691 2.
18. Jang JW Choi JY Bae SH, et al. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocelluar carcinoma. J Hepatol 2004 41 : 427 35.
19. Park JW. Practice guideline for diagnosis and treatment of hepatocellular carcinoma. Korean J Hepatol. 2004 10 ( 2 88 98.
20. Wong GC Tan P Goh YT, et al. Exacerbation of hepatitis B carriers following chemotherapy for haematological malignancies. Ann Acad Med Singapore 1996 25 : 500 3.
21. Steinberg JL Yeo W Zhong S, et al. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: Precore/core mutations may play an important role. J Med Virol 2000 60 : 249 55.
22. Caselitz M Link H Hein R, et al. Hepatitis B associated liver failure followed bone marrow transplantation. J Hepatol 1997 27 : 572 7.
23. Kubo S Nishiguchi S Hamba H, et al. Reactivation of viral replication after liver resection in patients infected with hepatitis. Ann Surg 2001 233 : 130 45.
24. Nagamatsu H Kumashiro R Itano S, et al. Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC. Hepatol Res. 2003 26 : 293 301.
25. Tamori A Nishiguchi S Tanaka M, et al. Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma. Hepatol Res. 2003 26 : 77 80.
26. Lok ASF McMahon BJ. Chronic hepatitis B: Update of recommendations. Hepatology 2004 39 : 1 5.
27. Liaw YF Sung JJY Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004 351 : 1521 31.
28. Llovet J Burroughs A Bruix J. Hepatocellular carcinoma. Lancet 2003 362 : 1907 17.
29. Lee HS Kim KM Yoon JH, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: A prospective cohort study. J Clin Oncol 2002 20 : 4459 65.
30. Matsui O Kadoya M Yoshikawa J, et al. Small hepatocellular carcinoma; treatment with subsegmental transcatheter arterial embolization. Radiology 1993 188 : 79 83.
31. Ueno K Miyazono N Inoue H, et al. Transcatheter arterial chemoemboization therapy using iodized oil for patients with unresectable hepatocellular carcinoma. Evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000 88 : 1574 81.